Patent · US Active

Marker molecules associated with lung tumors

US7883896B2 · kind B2 · utility

1Cited by

4References

16Claims

0Family size

Assignee

MTM Laboratories, AG · DE

Inventors

Johannes Coy · Otzberg, DE
Rainer Hipfel · Wiesbaden, DE
Birgit Wasser · Kornwestheim, DE

Key dates

Filing date	Mar 17, 2008
Grant date	Feb 8, 2011
Priority date	—
Expiry date	Mar 14, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to nucleic acids and polypeptides associated with lung cancer. The invention is more specifically related to a nucleic acids and the polypeptides transcribed thereof, the expression of which is significantly altered in association with lung cancer. The invention relates to a series of differentially spliced transcripts of the gene disclosed herein, that are associated with tumors of the respiratory tract. Furthermore the present invention provides a method for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as e.g. lung tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.